Filtered By:
Vaccination: Hepatitis Vaccine
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 4898 results found since Jan 2013.
Optimization of a cellular HBV infection model for use in high-throughput drug screening
In this study, we optimized an in vitro HBV infection model consisting of two cell lines: HepAD38 cells, which are able to produce infectious HBV; and HepG2-NTCP cells, which are susceptible to HBV infection. We showed that prolonged production of HBV in the "donor" cells and HBV inoculation of the "acceptor" cells simultaneously with seeding improves the established procedure. This modified protocol was proven effective in experiments involving compounds with known activity against HBV, suggesting its utility for future high-throughput screening. Keywords: HBV; HBV in vitro models; HepG2-NTCP; HepAD38.PMID:33827225 | DOI:10.4149/av_2021_110
Source: Acta Virologica - April 8, 2021 Category: Infectious Diseases Authors: Nadezhda P Kartashova Svetlana I Iarovenko Ekaterina A Glubokova Ilya A Potemkin Anastasia A Karlsen Irina A Leneva Karen K Kyuregyan Alexey A Ryakhovskiy Mikhail I Mikhailov Source Type: research
Birth and death notification via mobile devices: a mixed methods systematic review
CONCLUSIONS: We need more, well-designed studies of the effect of birth and death notification via mobile devices and on factors that may influence its implementation.PMID:34271590 | DOI:10.1002/14651858.CD012909.pub2
Source: Rural Remote Health - July 16, 2021 Category: Rural Health Authors: Lavanya Vasudevan Claire Glenton Nicholas Henschke Nicola Maayan John Eyers Marita S F ønhus Tigest Tamrat Garrett L Mehl Simon Lewin Source Type: research
The Possible Protective Effect of Hepatitis B Vaccine Against Lymphomas: A Systematic Review
CONCLUSION: Although the literature is still largely lacking regarding the protective effect of anti-HBV vaccination on lymphoma subtypes, the association between HBV infection and lymphoma has been confirmed in several studies. Vaccination programs eliminate the risk of HBV infection and prevent liver disease but can also indirectly reduce the risk of lymphomas.PMID:35049430 | DOI:10.2174/1389201023666220113111946
Source: Current Pharmaceutical Biotechnology - January 20, 2022 Category: Biotechnology Authors: Lorenza Lia Daniela Grima Francesca Amici Linda Manzi Alessandro Monaci Giuseppe La Torre Source Type: research
PreHevbrio: A New 3-Antigen Hepatitis B Vaccine for Adults
CONCLUSIONS: The 3A-HepB represents another vaccine to prevent hepatitis B in adults. It is safe and immunogenic but is associated with more adverse reactions than 1A-HepB.PMID:35906803 | DOI:10.1177/10600280221114469
Source: The Annals of Pharmacotherapy - July 30, 2022 Category: Drugs & Pharmacology Authors: Allana J Sucher Brandon J Sucher Elias B Chahine Source Type: research
